Normothermia in Patients With Acute Cerebral Damage
Status:
Unknown status
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of our study is to verify wherever normothermia (achieved with diclofenac
administration) may improve intracranial pressure control and may limit secondary cerebral
damage thus positively influencing outcome in patients with acute cerebral damage admitted to
ICU.
Phase:
Phase 4
Details
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico